Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY-NC-ND 4.0Kidney Medicine

Coexisting Reninoma and Aldosterone-Producing Nodule: A Case of Mixed Hyperaldosteronism

7 affiliations
  1. 1Department of Ultrasound, Shenzhen University General Hospital, Shenzhen, China
  2. 2Department of Pathology, Shenzhen University General Hospital, Shenzhen, China
  3. 3Department of Radiology, Shenzhen University General Hospital, Shenzhen, China
  4. 4Department of Nuclear Medicine, Shenzhen Hospital of Southern Medical University, Shenzhen, China
  5. 5Department of Endocrinology, Shenzhen University General Hospital, Shenzhen, China
  6. 6Department of Endocrinology, Peking University First Hospital, Beijing, China
  7. 7Department of Nephrology, Peking University First Hospital, Beijing, China

Abstract

Distinguishing primary aldosteronism from secondary hyperaldosteronism is traditionally based on reciprocal changes in plasma renin and aldosterone within the renin-angiotensin-aldosterone system (RAAS). We report a rare “mixed” hyperaldosteronism phenotype in a 41-year-old woman with a 14-year history of refractory hypertension and hypokalemia. Biochemical testing demonstrated extreme plasma renin elevation (1,872.00 μIU/mL) and high aldosterone (81.1 ng/dL), which initially suggested secondary hyperaldosteronism, but imaging identified the coexistence of a right renal mass and a right endocrine-active adrenal nodule. Following laparoscopic resection of both lesions, histopathology confirmed an atypical juxtaglomerular cell tumor (reninoma) with uncertain malignant potential (Ki-67 index 8%-10%) and an aldosterone-producing nodule (APN). Postoperatively, plasma renin normalized and refractory hypertension resolved without antihypertensive medication. The aldosterone secretion is considered to originate from both the autonomous APN that bypasses normal RAAS regulation and responsive non-neoplastic (zona glomerulosa) cells stimulated by chronic RAAS activation from the reninoma. This rare case of coexisting atypical reninoma and APN highlights the limitations of relying solely on renin-aldosterone patterns and emphasizes that comprehensive multimodal imaging and endocrine evaluation are necessary to resolve diagnostic paradoxes in complex secondary hypertension.

Related

  1. Coexisting adrenal hemangioma and aldosterone-producing micronodule presented as adrenal incidentaloma
    JCEM case reportsPeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismEurope PMC
  2. Inter- and intratumoral heterogeneity of aldosterone-producing adenomas: recent advances and clinical implications
    Masanori Murakami
    Endocrine JournalPeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismJ-STAGE
  3. Aldosterone-producing adrenocortical carcinoma presenting with severe, rapidly progressive hypokalemia: a case report and literature review
    Yukino Okimoto, Akinori Takedomi, Tsuguka Matsuda +10
    Endocrine JournalPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaJ-STAGE
  4. The Aldosterone–Immune Axis in Primary Aldosteronism: Linking Adrenal Pathogenesis to Systemic Inflammation and Target-Organ Damage
    Noorzaileen Eileena Zaidi, Elena Aisha Azizan, Adli Ali
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Aldosterone-Mediated Atrial Remodeling and Atrial Fibrillation: Molecular Mechanisms, Translational Insights and Implications for Cardiac Surgery
    Debora Emanuela Torre, Carmelo Pirri
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Cardiovascular medicineCrossref
BibTeX
@article{luo2026coexisting,
  title = {{Coexisting Reninoma and Aldosterone-Producing Nodule: A Case of Mixed Hyperaldosteronism}},
  author = {Jingna Luo and Xiao Li and Zonghua Wen and Wanjing Liu and Yong Li and Hongyan Pan and Qiang Li and Ang Li and Jicheng Lv and Qian Li},
  journal = {Kidney Medicine},
  year = {2026},
  month = sep,
  doi = {10.1016/j.xkme.2026.101525},
  url = {https://doi.org/10.1016/j.xkme.2026.101525},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Coexisting Reninoma and Aldosterone-Producing Nodule: A Case of Mixed Hyperaldosteronism
AU  - Jingna Luo
AU  - Xiao Li
AU  - Zonghua Wen
AU  - Wanjing Liu
AU  - Yong Li
AU  - Hongyan Pan
AU  - Qiang Li
AU  - Ang Li
AU  - Jicheng Lv
AU  - Qian Li
PY  - 2026
DA  - 2026/09/11
JO  - Kidney Medicine
DO  - 10.1016/j.xkme.2026.101525
UR  - https://doi.org/10.1016/j.xkme.2026.101525
AB  - Distinguishing primary aldosteronism from secondary hyperaldosteronism is traditionally based on reciprocal changes in plasma renin and aldosterone within the renin-angiotensin-aldosterone system (RAAS). We report a rare “mixed” hyperaldosteronism phenotype in a 41-year-old woman with a 14-year history of refractory hypertension and hypokalemia. Biochemical testing demonstrated extreme plasma renin elevation (1,872.00 μIU/mL) and high aldosterone (81.1 ng/dL), which initially suggested secondary hyperaldosteronism, but imaging identified the coexistence of a right renal mass and a right endocrine-active adrenal nodule. Following laparoscopic resection of both lesions, histopathology confirmed an atypical juxtaglomerular cell tumor (reninoma) with uncertain malignant potential (Ki-67 index 8%-10%) and an aldosterone-producing nodule (APN). Postoperatively, plasma renin normalized and refractory hypertension resolved without antihypertensive medication. The aldosterone secretion is considered to originate from both the autonomous APN that bypasses normal RAAS regulation and responsive non-neoplastic (zona glomerulosa) cells stimulated by chronic RAAS activation from the reninoma. This rare case of coexisting atypical reninoma and APN highlights the limitations of relying solely on renin-aldosterone patterns and emphasizes that comprehensive multimodal imaging and endocrine evaluation are necessary to resolve diagnostic paradoxes in complex secondary hypertension.
SN  - 2590-0595
ER  -